Berlin Institute of Health partners with Startupbootcamp Digital Health

Startupbootcamp, a global network of industry‐focused start‐up accelerators, runs 20 programs across five continents with a mentor and alumni network in over 30 countries. Startupbootcamp Digital Health Berlin is a leading program in Europe supporting innovative companies combining medical knowledge with smart technologies, with a special focus on behavioral change, big data and analytics, diagnostics and genomics.

“This partnership enables us to facilitate knowhow transfer between digital health start‐ups applying new technologies to advanced healthcare problems and the academic hospital Charité – Universitätsmedizin Berlin to benefit patients,” says Dr. Rolf Zettl, CFO and Member of the Executive Board of BIH. “We look forward to also explore collaboration opportunities for transformational digital health solutions with the other partners.” Partners include Philips, Sanofi in Germany, Vilua, Deutsche Apotheker‐ und Ärztebank and Munich Re.

The Startupbootcamp program provides 10 globally‐screened digital health start‐ups with hands‐on mentorship from over 100 industry experts, logistics support, office space in Berlin, and access to a global network of corporate partners and investors from across the healthcare industry. Two teams of Charité innovators are co‐located with the program as Entrepreneurs in Residence to benefit from knowhow transfer with start‐ups and mentors.

“This partnership creates common ground for BIH and SBC with the great potential to bring some truly innovative solutions to the heart of German healthcare,” says Lars Buch, Managing Director of Startupbootcamp Digital Health Berlin.

With this initiative, BIH further strengthens its commitment to supporting translational medicine in digital health, amongst other areas, to improve patients’ health and quality of life.

Program details:


About Berlin Institute of Health (BIH)

Berlin Institute of Health (BIH) is a biomedical research institution focusing on translational research and precision medicine. BIH is dedicated to improving the prediction in progressive diseases and developing advanced therapies for unmet medical needs in order to improve patients’ health and quality of life. The Institute is committed to providing excellent research solutions and innovation enabling value-based, personalized healthcare. The two founding institutions, Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), are independent member entities within BIH.


Alexandra Hensel
Head of Communications and Marketing

Tim Huse
Head of Life Science Incubator and Digital Health Accelerator
Follow us on twitter @berlinnovation

Nach oben scrollen